1,387
Views
6
CrossRef citations to date
0
Altmetric
Clinical Study

Etiological analysis of graft dysfunction following living kidney transplantation: a report of 366 biopsies

, , , , , & show all
Pages 219-225 | Received 23 Oct 2017, Accepted 15 Mar 2018, Published online: 05 Apr 2018

References

  • Williams WW, Taheri D, Tolkoff-Rubin N, et al. Clinical role of the renal transplant biopsy. Nat Rev Nephrol. 2012;8:110–121.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9:S1–S157.
  • Ters ME, Grande JP, Keddis MT, et al. Kidney allograft survival after acute rejection, the value of follow‐up biopsies. Am J Transplant. 2013;13:2334–2341.
  • Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2011;364:485–486.
  • Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4:378–383.
  • Poduval RD, Kadambi PV, Josephson MA, et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005;79:228–235.
  • Sun Q, Liu ZH, Ji S, et al. Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int. 2006;70:377–383.
  • Lorenz M, Regele H, Schillinger M, et al. Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort. Transplantation. 2004;78:447–452.
  • Faravardeh A, Eickhoff M, Jackson S, et al. Predictors of graft failure and death in elderly kidney transplant recipients. Transplantation. 2013;96:1089–1096.
  • Moreso F, Alonso A, Gentil MA, et al. Improvement in late renal allograft survival between 1990 and 2002 in Spain: results from a multicentre case–control study. Transpl Int. 2010;23:907–913.
  • Sellares J, Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12:388–399.
  • Gago M, Cornell LD, Kremers WK, et al. Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant. 2012;12:1199–1207.
  • Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation. 2010;89:1–14.
  • Andradesierra J, Rojascampos E, Cardonamuñoz E, et al. Early steroid withdrawal in recipients of a kidney transplant from a living donor: experience of a single Mexican center. Transplant Proc. 2015;48:42–49.
  • Cantarovich D, Rostaing L, Kamar N, et al. Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized study. Am J Transplant. 2014;14:2556.
  • Kukla A, Chen E, Spong R, et al. Recurrent glomerulonephritis under rapid discontinuation of steroids. Transplantation. 2011;91:1386–1391.
  • Von Visger JR, Gunay Y, Andreoni KA, et al. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression. Clin Transplant. 2014;28:845–854.
  • Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002;347:103–109.
  • Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol. 2010;5:2363–2372.
  • Lai KN. Pathogenesis of IgA nephropathy. Nat Rev Nephrol. 2012;8:275–283.
  • McDonald SP, Russ GR. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation. 2006;82:759–762.
  • Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis. 1988;12:371–372.
  • Nijim S, Vujjini V, Alasfar S, et al. Recurrent IgA nephropathy after kidney transplantation. Transplant Proc. 2016;48:2689–2694.
  • Floege J, Gröne HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transpl. 2013;28:1070–1073.
  • Couser W. Recurrent glomerulonephritis in the renal allograft: an update of selected areas. Exp Clin Transplant. 2005;3:283–288.
  • Moroni G, Gallelli B, Quaglini S, et al. Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Transpl Int. 2010;23:208–216.
  • Huang G, Wang C, Chen LZ, et al. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis. Diagn Micr Infect Dis. 2015;81:21–26.
  • Wunderink HF, Meijden E, Brouwer BD, et al. Pretransplantation donor-recipient pair seroreactivity against BK polyomavirus predicts viremia and nephropathy after kidney transplantation. Am J Transplant. 2017;17:161–172.